Skip to Content

05/10 Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Esperion Therapeutics, Inc.

To join this class action, please complete the following Investor Certification.   Oklahoma City, OK (May 10, 2018) – On May 7, 2018, a securities class action lawsuit was filed in the United States District Court for the District of Michigan against Esperion Therapeutics, Inc. (NASDAQ: ESPR).  The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is February 22, […]

05/04 Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against LendingClub Corporation

To join this class action, please complete the following Investor Certification.   Oklahoma City, OK (May 4, 2018) – On May 2, 2018, a securities class action lawsuit was filed in the United States District Court for the Northern District of California against LendingClub Corporation (NYSE: LC).  The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is February 28, […]

04/30 Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Molina Healthcare, Inc.

To join this class action, please complete the following Investor Certification.   Oklahoma City, OK (April 30, 2018) – On April 27, 2018, a securities class action lawsuit was filed in the United States District Court for the Central District of California against Molina Healthcare, Inc. (NYSE: MOH).  The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is October […]

04/26 Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Edge Therapeutics, Inc.

To join this class action, please complete the following Investor Certification.   Oklahoma City, OK (April 26, 2018) – On April 23, 2018, a securities class action lawsuit was filed in the United States District Court for the District of New Jersey against Edge Therapeutics, Inc. (NASDAQ: EDGE).  The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is December […]

04/26 Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Macquarie Infrastructure Corporation

To join this class action, please complete the following Investor Certification.    Oklahoma City, OK (April 26, 2018) – On April 23, 2018, a securities class action lawsuit was filed in the United States District Court for the Southern District of New York against Macquarie Infrastructure Corporation (NYSE: MIC).  The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which […]

04/26 Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Gridsum Holding, Inc.

To join this class action, please complete the following Investor Certification.  Oklahoma City, OK (April 26, 2018) – On April 25, 2018, a securities class action lawsuit was filed in the United States District Court for the Southern District of New York against Gridsum Holding, Inc. (NASDAQ: GSUM).  The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is […]

04/23 Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Myriad Genetics, Inc.

If you purchased shares of Myriad Genetics, Inc. between August 13, 2014 through March 12, 2018 and would like to join the class action, please complete the following Investor Certification.  Oklahoma City, OK (April 23, 2018) – On April 20, 2018, a securities class action lawsuit was filed in the United States District Court for the District of Utah against Myriad Genetics, Inc. (NASDAQ: MYGN).  The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the […]

04/23 Federman & Sherwood Announces Class Certification of UTi Worldwide, Inc. Litigation

The law firm of Federman & Sherwood announces that on April 19, 2018 the Court entered an Order granting Plaintiff’s Motion for Class Certification.  The certified class is defined as “all persons and entities who purchased shares of UTi Worldwide, Inc., (“UTi”) common stock during the period from March 28, 2018 through February 25, 2014, inclusive, and were damaged by the alleged false and misleading statements.”  Federman & Sherwood was also appointed as Class Counsel.  The case was filed in the United States District Court for the Central District of California styled Michael J. Angley, individually and on Behalf of […]

04/13 Settlement Notice LeapFrog Enterprises, Inc. (NYSE: LF)

To:  All persons and/or entities who purchased common stock in LeapFrog Enterprises, Inc. (NYSE: LF) during the period from  May 5, 2014 through January 22, 2015 , and were damaged thereby; a settlement has been announced in the securities litigation known as In  re LeapFrog Enterprises, Inc. Securities Litigation, Master File No. 3:15-cv-00347-EMC,  United States District Court for the  Northern District of California.  For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed Settlement of Class Action and Settlement Fairness Hearing; Proof of Claim and Release. Claim submission […]

04/13 Settlement Notice (Updated) – KaloBios Pharmaceuticals, Inc. (NASDAQ: KBIO)

To:  All persons and/or entities who purchased common stock in KaloBios Pharmaceuticals, Inc. [NASDAQ: KBIO] during the period from November 18, 2015 to December 16, 2015, inclusive and were damaged thereby; a settlement has been announced in the securities litigation known as In re KaloBios Pharmaceuticals, Inc. Securities Litigation, Case No. 5:15-cv-05841, United States District Court for the Northern District of California..  For additional information about this settlement, please see the Notice and Proof of Claim (links provided below):                                            […]

let’s connect

Click Here to Complete Federman & Sherwood Fee Agreement.

OKLAHOMA Office

10205 North Pennsylvania Avenue
Oklahoma City, Oklahoma 73120

TEXAS Office

212 W. Spring Valley Road,
Richardson, Texas 75081